Privia Health Reports Strong Q3 2026 Results and Raises Full-Year Guidance
Privia Health (PRVA) reported robust third-quarter 2026 financial results, characterized by a 13.2% year-over-year increase in total revenue to $657 million. Net income saw a significant surge of 96.6%, reaching $13.5 million, while Adjusted EBITDA grew 6.3% to $40.6 million. The company's growth was primarily driven by new provider implementations and strong ambulatory utilization. Driven by strong year-to-date performance, management raised its full-year 2026 guidance for both revenue ($2.50 billion to $2.55 billion) and Adjusted EBITDA ($154 million to $157 million). Strategic moves include the upcoming acquisition of American Choice Healthcare to expand geographic footprint and an exit from a Montana partnership, which is expected to have no material impact on 2027 earnings.
Tickers: $PRVA
Topics: EBITDA healthcare services M&A net income increase revenue growth